Screener / SEC EDGAR /CIK 0001632970 /10-K filed Feb 27, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Real estate · REIT

American Healthcare REIT, Inc. AHR

Compare with peers Embed
FY2025 at a glance

Sales up 9.1%

XBRL, from each 10-K
RevenueStatements
$2.3B from $2.1B in FY2024
FY2016FY2025
Net incomeStatements
$69.8M from -$37.8M in FY2024
FY2016FY2025
EPS (diluted)Statements
$0.42 from $-0.29 in FY2024
FY2016FY2025
Operating marginStatements
18.4% from 17.6% in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (38)
EPS (ttm)
0.49
Sales (ttm)
2.7B
Net income (ttm)
96.3M
Sales growth
+9.1%
EPS growth
-
Sales Q/Q
+29.5%
Free cash flow
-
Gross margin
-
Oper. margin
20.2%
Net margin
3.6%
FCF margin
-
ROE
1.7%
ROA
1.3%
R&D / sales
-
Dividend
1.00
Debt/Eq
-
Curr. ratio
-
Cash
222.8M
Op. cash flow (ttm)
421.7M
EBITDA
602.7M
EBITDA margin
26.7%
Interest cover
4.84
ROIC
10.9%
Payout ratio
n/m
Goodwill / assets
4.3%
Oper. margin low 5y
16.4%
Tax rate
-45.6%
Stock pay / sales
0.6%
Shares out.
232.1M
Shares Y/Y
+27.7%
Book / share
23.85
Cash / share
0.96
Sales / share
11.51
Asset turnover
0.35
Inventory turns
95.21
Sales 3Y CAGR
+17.0%
Sales 5Y CAGR
+16.2%
EPS 5Y CAGR
+53.1%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 2.3B +107.6% a year Net income 69.8M
FY2016 revenue 3.2M · Revenues, 0001632970-19-000034 FY2016 net income -5.5M · NetIncomeLoss, 0001632970-19-000034 3.2M FY2016 FY2017 revenue 33.3M · Revenues, 0001632970-20-000016 FY2017 net income 541K · NetIncomeLoss, 0001632970-20-000016 33.3M FY2017 FY2018 revenue 84.5M · Revenues, 0001632970-21-000028 FY2018 net income -8.4M · NetIncomeLoss, 0001632970-21-000028 84.5M FY2018 FY2019 revenue 1.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001632970-22-000020 FY2019 net income -5.0M · NetIncomeLoss, 0001632970-22-000020 1.1B FY2019 FY2020 revenue 1.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001632970-23-000029 FY2020 net income 2.2M · NetIncomeLoss, 0001632970-23-000029 1.1B FY2020 FY2021 revenue 1.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001632970-24-000039 FY2021 net income -47.8M · NetIncomeLoss, 0001632970-24-000039 1.1B FY2021 FY2022 revenue 1.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001632970-25-000018 FY2022 net income -81.3M · NetIncomeLoss, 0001632970-25-000018 1.4B FY2022 FY2023 revenue 1.9B · Revenues, 0001193125-26-082692 FY2023 net income -71.5M · NetIncomeLoss, 0001193125-26-082692 1.9B FY2023 FY2024 revenue 2.1B · Revenues, 0001193125-26-082692 FY2024 net income -37.8M · NetIncomeLoss, 0001193125-26-082692 2.1B FY2024 FY2025 revenue 2.3B · Revenues, 0001193125-26-082692 FY2025 net income 69.8M · NetIncomeLoss, 0001193125-26-082692 2.3B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share +53.1% a year FY2020 $0.05 to FY2025 $0.42, 5 years
Book value per share -17.9% a year FY2019 $64.87 to FY2025 $19.90, 6 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $0.42$19.90-
Dec 31, 2024 -$0.29$17.31-
Dec 31, 2023 -$1.08$19.23-
Dec 31, 2022 -$1.24$21.28-
Dec 31, 2021 -$0.95$31.57-
Dec 31, 2020 $0.05$19.26-
Dec 31, 2019 -$0.60$64.87-
Dec 31, 2018 ---
Dec 31, 2017 ---
Dec 31, 2016 ---
Dec 31, 2015 ---

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Tangible book value, FY2025, in dollars
  • + Shareholders' equity $3.3B
  • − Goodwill $234.9M
  • − Other intangible assets $253.2M
  • = Tangible book value $2.8B
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

AHR against Real estate peers

Among the 97 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+1.3%+10.4%
+9.1%31st of 89 · median +6.1%
Net margin
5.9%35.6%
3.6%74th of 90 · median 19.9%
Return on equity
2.5%11.3%
1.7%74th of 93 · median 7.0%
AHR and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
AHR American Healthcare REIT, Inc.$2.7B +9.1%-3.6%1.7%--
RHP Ryman Hospitality Properties, Inc.$2.8B +10.2%43.7%9.9%20.2%--
ARE Alexandria Real Estate Equities$2.8B -2.9%--51.8%-9.7%-0.87
CXW CoreCivic, Inc.$2.6B +12.7%-54.6%63.5%-14.9%0.27
COLD Americold Realty Trust$2.6B -2.4%29.9%9.0%7.9%-5.1%-
HHH Howard Hughes Holdings Inc.$2.6B -15.8%-6.5%4.3%-1.29
All 97 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by region

From $2.3B of sales to $69.8M of profit FY2025

  • United States $2.3B
  • International $6.5M
Revenue to Gross profit: $466.6MRevenue to Cost of revenue: $1.8BGross profit to Operating profit: $415.2MGross profit to Operating expenses: $51.4MOperating profit to Net profit: $69.8MOperating profit to Interest, tax, other: $345.4M Revenue: $2.3B REVENUE $2.3B +9% Y/Y Gross profit: $466.6M · 21% margin GROSS PROFIT $466.6M 21% margin Cost of revenue: $1.8B · 79% of revenue COST OF REVENUE $1.8B 79% of revenue Operating profit: $415.2M · 18% margin OPERATING PROFIT $415.2M 18% margin · +14% Y/Y Operating expenses: $51.4M · 2% of revenue OPERATING EXPENSES $51.4M 2% of revenue Net profit: $69.8M · 3% margin NET PROFIT $69.8M 3% margin Interest, tax, other: $345.4M · 15% of revenue INTEREST, TAX, OTHER $345.4M 15% of revenue

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity 2.1% FY2020: 0.2% net income ÷ equity
Net margin 3.1% FY2020: 0.2% profit per $ of sales: 69.8M ÷ 2.3B
Asset turnover 0.42× FY2020: 0.33× sales per $ of assets: 2.3B ÷ 5.4B
Leverage 1.63× FY2020: 3.74× assets per $ of equity: 5.4B ÷ 3.3B

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    3.6% vs 19.9%
  • Return on equity below 15%
    1.7%
  • A profit in 3 of 10 years
Net margin, FY2016 to FY2025: -173.4% to 3.1%

Cash and shareholders

  • Share count up over 5 years
    +85.5%
  • Dividend per share up over 5 years
    $0.86 → $1.00
  • Cash from operations above net income
    $294.4M vs $69.8M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$257.6M of principal due, schedule of Sep 30, 2026

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

AHR's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue2.3B
FY2016: 3.2MFY2017: 33.3MFY2018: 84.5MFY2019: 1.1BFY2020: 1.1BFY2021: 1.1BFY2022: 1.4BFY2023: 1.9BFY2024: 2.1BFY2025: 2.3B FY2017FY2019FY2021FY2023FY2025
Net income69.8M
FY2016: -5.5MFY2017: 541KFY2018: -8.4MFY2019: -5.0MFY2020: 2.2MFY2021: -47.8MFY2022: -81.3MFY2023: -71.5MFY2024: -37.8MFY2025: 69.8M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)0.42
FY2016: -35.00FY2017: 0.40FY2018: -3.00FY2019: -0.60FY2020: 0.05FY2021: -0.95FY2022: -1.24FY2023: -1.08FY2024: -0.29FY2025: 0.42 FY2017FY2019FY2021FY2023FY2025
Dividend per share1.00
FY2016: 8.00FY2017: 12.00FY2018: 12.00FY2019: 13.00FY2020: 0.86FY2021: 0.69FY2022: 1.60FY2023: 1.00FY2024: 1.00FY2025: 1.00 FY2017FY2019FY2021FY2023FY2025
Diluted shares166.8M
FY2016: -FY2017: -FY2018: -FY2019: 9.1MFY2020: 45.0MFY2021: 50.1MFY2022: 65.8MFY2023: 66.0MFY2024: 130.6MFY2025: 166.8M FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Dec 31, 2025
RevenueSharevs year before
Integrated Senior Health Campuses 1.8B78.0% +8.9%
SHOP 330.6M14.6% +25.2%
Outpatient Medical 00.0% -
Triple-Net Leased Properties 00.0% -

10-K 0001193125-26-082692, segment and revenue notes (XBRL).

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
United States 2.3B99.7% +9.2%
International 6.5M0.3% -1.7%

10-K 0001193125-26-082692, segment and revenue notes (XBRL).

Revenue by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Integrated Senior Health Campuses1.0B1.3B1.5B1.6B1.8B
SHOP98.2M157.5M186.9M264.0M330.6M
Outpatient Medical00000
Triple-net leased properties00000

Operating income by business segment, 5 years

from the segment notes of the last 3 10-Ks
FY2021FY2022FY2023FY2024FY2025
Integrated Senior Health Campuses95.9M146.0M153.5M189.3M237.0M
Outpatient Medical60.9M92.3M91.6M83.9M77.4M
SHOP14.8M10.3M20.4M40.6M64.0M
Triple-net leased properties41.7M53.3M41.3M49.8M36.8M

Revenue and operating income by business segment, as each 10-K reports them in its segment note (XBRL). Each year comes from the newest 10-K that reports it, so a year the company later recast shows the recast number; click a number to open that 10-K. Rows without a number were not reported as a separate segment that year. "Corporate and other" and "All other" are the 10-K's own lines for what is outside the segments.

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3.2M33.3M84.5M1.1B1.1B1.1B1.4B1.9B2.1B2.3B
Cost of revenue898K7.3M11.5M19.2M993.7M1.0B1.3B1.5B1.7B1.8B
SG&A1.2M4.3M9.2M29.7M27.0M43.2M43.4M47.5M47.6M58.7M
Operating income-5.0M--221.4M218.3M213.3M302.0M306.8M363.5M415.2M
Interest expense514K2.7M6.8M78.6M71.3M80.9M106.0M163.2M127.7M85.8M
Pretax income-5.5M508K-8.6M672K5.8M-52.3M-72.8M-76.2M-33.9M48.6M
Income tax008K1.5M-3.1M956K586K663K1.7M-22.2M
Net income-5.5M541K-8.4M-5.0M2.2M-47.8M-81.3M-71.5M-37.8M69.8M
EPS (diluted)-35.000.40-3.00-0.600.05-0.95-1.24-1.08-0.290.42
Diluted shares---9.1M45.0M50.1M65.8M66.0M130.6M166.8M
Depreciation & amortization1.3M13.6M32.7M111.4M98.9M133.2M168.0M182.6M179.2M187.6M
EBITDA-3.7M--332.8M317.1M346.5M469.9M489.4M542.7M602.7M
Operating margin-157.2%--20.1%20.4%19.0%21.4%16.4%17.6%18.4%
Net margin-173.4%1.6%-9.9%-0.5%0.2%-4.3%-5.8%-3.8%-1.8%3.1%
Revenue growth-+956%+153%+1201%-2.7%+5.1%+25.6%+32.2%+10.9%+9.1%
EPS growth--to a loss--to a loss----

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)80K131K185K2.7M-1.3M8.8M3.9M5.5M9.9M14.6M
Stock-based pay / revenue2.5%0.4%0.2%0.2%-0.1%0.8%0.3%0.3%0.5%0.6%
Operating lease cost---30.0M32.4M23.8M30.6M44.1M38.3M34.4M
Operating lease cash paid---22.1M23.8M16.8M-36.6M33.3M30.0M
Finance lease principal paid---3.1M1.2M170K54K62K81K56K
Right-of-use assets--014.3M204.0M158.2M276.3M227.8M164.0M135.4M
Operating lease liabilities--09.9M193.6M145.5M273.1M225.5M165.2M135.6M
Finance lease liabilities-----148K150K100K139K33.9M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AHR/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.